COMP <GO>
MOH vs CAI // FORWARD P/E MULTIPLE
Molina Healthcare Inc (NYSE) VS. Caris Life Sciences Inc. (NASDAQ) • 15-METRIC TALLY: MOH 6
— CAI 6
▲ FORWARD P/E MULTIPLE LEADER: MOH
LAST: $204.78 (+2.93%) • MKT CAP: $10.39B
forward-pe
20.5x
LAST: $34.33 (-5.01%) • MKT CAP: $10.21B
forward-pe
21.0x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (MOH VS. CAI)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | MOH | CAI | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 13.10% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 17.20% | 4.40% | +12.80 | MOH | /roic <GO> |
| EV/EBITDA & P/E Valuation | 11.4x | 95.0x | -83.60 | MOH | /valuation <GO> |
| Free Cash Flow Yield | -6.12% | 0.65% | -6.77 | CAI | /fcf-yield <GO> |
| Operating Margin | 1.70% | 5.60% | -3.90 | CAI | /operating-margins <GO> |
| Net Profit Margin | 1.00% | -8.40% | +9.40 | MOH | /net-margins <GO> |
| Revenue Growth (YoY) | 11.70% | 97.00% | -85.30 | CAI | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 4.34 | 9.79 | -5.45 | CAI | /balance-sheet <GO> |
| Piotroski F-Score Quality | 4/9 | 8/9 | -4.00 | CAI | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 46.2 | 67.6 | -21.40 | CAI | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.94 | 0.91 | +0.03 | MOH | /macro-sensitivity <GO> |
| Forward P/E Multiple ACTIVE | 20.5x | 21.0x | -0.50 | MOH | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $10.39B | $10.21B | $172.2M | MOH | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | MOH REV | CAI REV | MOH GROSS % | CAI GROSS % | MOH FCF | CAI FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $45.43B | $812.0M | 13.1% | — | -$636.0M | $66.9M |
| FY 2024 | $40.65B | $412.3M | 15.3% | — | $544.0M | -$253.6M |
| FY 2023 | $34.07B | $306.1M | — | — | $128.8M | -$289.9M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
MOH // BETA 0.94
CAI // BETA 0.91